{"id":244496,"title":"Literature Review Update on the Efficacy and Effectiveness of High-Dose (Fluzone® High-Dose) and MF59-Adjuvanted (Fluad®) Trivalent Inactivated Influenza Vaccines in Adults 65 Years of Age and Older - Executive Summary - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2025-04-18","captureTimestamp":"2025-04-18T19:03:20.499000+00:00","jobId":1,"originalUrl":"https://www.canada.ca/en/public-health/services/publications/healthy-living/executive-summary-literature-review-update-efficacy-effectiveness-fluzone-high-dose-fluad-trivalent-inactivated-influenza-vaccines-adults-65-older.html?wbdisable=false","snippet":"Literature Review Update on the Efficacy and Effectiveness of High-Dose (Fluzone® High-Dose) and MF59-Adjuvanted (Fluad®) Trivalent Inactivated Influenza Vaccines in Adults 65 Years of Age and Older - Executive Summary - Canada.ca Skip to main content Skip to \"About government\"…","rawSnapshotUrl":"/api/snapshots/raw/244496","browseUrl":"https://replay.healtharchive.ca/job-1/20250418190320/https://www.canada.ca/en/public-health/services/publications/healthy-living/executive-summary-literature-review-update-efficacy-effectiveness-fluzone-high-dose-fluad-trivalent-inactivated-influenza-vaccines-adults-65-older.html?wbdisable=false#ha_snapshot=244496","mimeType":"text/html","statusCode":200}